ArticleCancer immunology, immunotherapy : CII2023

TGF-β1 mediates tumor immunosuppression aggravating at the late stage post-high-light-dose photodynamic therapy.

Lingfei Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.